#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multiple system atrophy Basal cell naevus syndrome Autoimmune demyelinating disease Congenital hypotransferrinaemia Hereditary motor and sensory neuropathy Myelin oligodendrocyte glycoprotein antibody-associated disease Kaposi's sarcoma Haemophilia B with anti factor IX Mantle cell lymphoma recurrent Acute lymphocytic leukaemia recurrent Malignant melanoma Amyloidosis Lymphoma Isodicentric chromosome 15 syndrome Anti-myelin-associated glycoprotein associated polyneuropathy More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Diagnostics Small intestine leiomyosarcoma Phenylketonuria – Diagnostics Hereditary motor and sensory neuropathy Mantle cell lymphoma – Basic Information Burkitt’s lymphoma – Life with Disease Mucopolysaccharidosis – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics Proteus syndrome – Basic Information Haemophilia B with anti factor IX – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isotretinoin Canakinumab Prucalopride Surzebiclimab Regn7257 Naloxone Linagliptin Interleukin-2 Oritavancin Streptococcus Pneumoniae Dabigatran Etexilate Bi 765845 Sodium Zirconium Cyclosilicate Alks 2680 LY4170156 Bevacizumab Clioquinol Granisetron AZD4360 Rly-4008 More therapies…

    Learn about Your Condition

    Malignant melanoma stage III Gastrointestinal carcinoma Spinal pain Gout Nephrogenic anaemia Endometrial cancer stage III Giant cell arteritis Yellow fever Adenocarcinoma pancreas Intestinal obstruction Myofascial pain syndrome Viral myocarditis Deafness traumatic Herpes virus infection Malignant peritoneal neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Sud Francilien

Centre Hospitalier Sud Francilien

40 Avenue Serge Dassault, Corbeil Essonnes, 91100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Obinutuzumab in patients with pure class V lupus nephritis (systemic lupus erythematosus membranous nephropathy) – phase II trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Obinutuzumab
    France

  • Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Azacitidine
    • Everolimus
    • Tofacitinib
    Czechia France Germany The Netherlands Spain

  • A study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Adalimumab
    • Bimekizumab
    France

  • Study evaluating the effect of levetiracetam on recovery in patients with intracerebral haemorrhage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Levetiracetam
    France

  • Comparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Tenecteplase
    France

  • Comparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Dexamethasone Acetate
    • Etoposide
    France

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amphotericine B, Liposome
    • Anidulafungin
    • Caspofungin
    France

  • Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Pirtobrutinib
    France

  • Study comparing low-dose versus standard-dose epinephrine for better brain recovery in patients with out-of-hospital cardiac arrest

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Epinephrine Bitartrate
    France

  • Study comparing 3-week versus 6-week antibiotic treatment for patients with drained pyogenic liver abscess

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amikacin Sulfate
    • Avibactam
    • Bromhexine Hydrochloride
    France
Previous Page
1 2 3 4 5 6 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!